ArticleAnnals of surgical oncology2026
Social Vulnerability as a Neighborhood-Level Determinant of Pancreatic Cancer Survivorship: A National Analysis of Veterans Affairs Patients.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVeterans Affairs (VA) patients participate within the largest USA equal-access healthcare system, though still experience cancer mortality disparities by social determinants. The Social Vulnerability Index (SVI)-measuring community poverty, minority status, housing, and transportation-has delineated gradients in cancer care utilization and outcomes. We therefore assessed relationships between SVI and mortality in veterans with pancreatic ductal adenocarcinoma (PDAC). PATIENTS AND
methodsRecords of patients with stage I-III PDAC diagnosed January 2005-December 2018 were abstracted from the VA Corporate Data Warehouse. Addresses were geocoded to SVI. Mann-Whitney U and chi-squared tests compared baseline characteristics. Overall survival (OS) was compared using Kaplan-Meier and multivariable Cox proportional hazards methods.
resultsA total of 1778 patients were evaluated, of which 570 (32%) underwent surgical resection. A total of 516 (29%) patients originated from census tracts in the highest SVI quartile. These patients were more likely Black (38% vs 13%), unemployed (49% vs 35%), and metropolitan-based (87% vs 76%; all p < 0.001). Over a median follow-up of 8.7 months, median OS was 9.5 months versus 10.2 months for high and low SVI groups, respectively (log-rank p = 0.03). In the resected cohort, high and low SVI groups reflected a median OS of 18.2 months versus 23.1 months, respectively (log-rank p < 0.01). High SVI remained independently associated with mortality for resected patients only (hazard ratio [HR] 1.4, p < 0.01).
conclusionsHigh SVI was associated with poorer prognosis after PDAC resection. Acknowledging a need to identify mechanisms, SVI has potential use in triaging PDAC survivorship interventions in veterans.
Indexed as
Identifiers
40897942What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.